Summarize this content material to 1000 phrases
(HealthDay Information) — The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44% of COVID-19 circumstances, up from roughly 7% in late November, the newest information from the US Facilities for Illness Management and Prevention present.
The velocity at which the JN.1 variant has unfold this month suggests it might unfold extra simply and be higher at evading immune techniques than different circulating variants, in line with a latest CDC report. “It’s too early to know whether or not or to what extent JN.1 will trigger a rise in infections or hospitalizations,” the CDC stated in its report.
Fortunately, JN.1 doesn’t appear to be inflicting extra extreme sickness but. Moreover, the up to date COVID-19 vaccines that had been launched in September produce antibodies that work towards JN.1, which is distantly associated to the XBB.1.5 variant the tweaked vaccines goal.
Although JN.1 might not trigger extra extreme illness than different variants, hospitalizations have began creeping up just lately. For the week of Dec. 10, there have been slightly below 26,000 COVID-19-linked hospitalizations, a ten% enhance from about 23,000 hospitalizations the week earlier than. Nonetheless, these numbers are nonetheless far decrease than they had been throughout the peak of the tripledemic final winter, when COVID-19, flu and respiratory syncytial virus circumstances all surged concurrently.